Syntis Bio Doses First Patient in SYNT-101 Trial
03 Mar 2026 //
BUSINESSWIRE
Syntis Bio secures $38M to speed up oral therapies for obesity
01 Jul 2025 //
BUSINESSWIRE
Syntis Bio Releases New Data on SYNT-101 for Obesity at European
10 Apr 2025 //
BUSINESSWIRE

Market Place
Sourcing Support